A world-leading health company is seeking novel therapeutics for obesity, with safety and efficacy data, preferably in canine models. Approaches should help manage obesity and reduce body condition score, with greater efficacy than diet and/or exercise alone. Our client aims to bring a novel treatment to market within 3-5 years.
Approaches should allow for oral or injectable delivery, ideally with daily (oral) or monthly (injectable) dosing. Our client is seeking therapeutics with strong safety profile, with minimal side-effects (i.e. no gastrointestinal...